The biotechnology company's potential COVID-19 vaccine proved to be highly effective in a key study. Ulta Beauty Inc., down $29.35 to $318.15.
News
- Novavax, Vail Resorts rise; Ulta Beauty, Zumiez fall
- Rare yellow cardinal visits Illinois family, attracts national attention
Both media outlets contacted Geoffrey Hill, an Auburn University biological sciences professor, who specializes in studying feather pigmentation.
- Texas BioMed CEO reflects on its crucial role in vaccine development
SAN ANTONIO – “Wow, what a year it has been,” said Dr. Larry Schlesinger, president and CEO of the Texas Biomedical Research Institute, about the ...
- Histogen: Q4 Earnings Snapshot
The biotechnology company posted revenue of $478,000 in the period. For the year, the company reported that its loss widened to $18.8 million, ...
- Capricor: Q4 Earnings Snapshot
The biotechnology company posted revenue of $57,800 in the period. Its adjusted revenue was $58,000. For the year, the company reported that its ...